The chart is not accessible to screen readers. Please switch to the table view to access the data.
By 2031, the in-silico drug discovery market worldwide is expected to be valued at *** billion U.S. dollars. As of 2021, the market was valued at just *** billion U.S. dollars. The largest segment of the in-silico drug discovery market is software as a service (SaaS). 'In-silico' in general means that testing is done by computer simulation, as in contrast to 'in vivo' or 'in vitro'. In-silico testing was used, for example, in the search for existing drugs which could potentially be used as therapy or cure for COVID-19. In-silico is believed to have great potential for speeding up drug discovery because expensive laboratory work and clinical trials could be reduced.
Log in or register to access precise data.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
About the industry
About the region
Selected statistics
Other regions
Related statistics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
